154 related articles for article (PubMed ID: 111693)
21. Coronary heart disease. Hemodynamic response to exercise before and after nitroglycerin.
Di Giorgi S; West RO; Parker JO
Mal Cardiovasc; 1968; 9(1):29-50. PubMed ID: 4981691
[No Abstract] [Full Text] [Related]
22. [Effect of glycerol trinitrate on R-amplitude in patients with chronic ischemic heart disease].
Teichmann W
Z Kardiol; 1989; 78 Suppl 2():112-4; discussion 115-7. PubMed ID: 2511682
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia.
Cocco G; Strozzi C; Chu D; Amrein R; Castagnoli E
Eur J Cardiol; 1979 Jul; 10(1):59-69. PubMed ID: 111940
[TBL] [Abstract][Full Text] [Related]
24. Comparison of metoprolol and verapamil in the treatment of angina pectoris.
Arnman K; Rydén L
Am J Cardiol; 1982 Mar; 49(4):821-7. PubMed ID: 6801951
[TBL] [Abstract][Full Text] [Related]
25. [Metoprolol in angina pectoris].
Weintraub M; Rabinovitz B; Glaziewski V; Neufeld HN
Harefuah; 1981 Apr; 100(8):367-9. PubMed ID: 7274804
[No Abstract] [Full Text] [Related]
26. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
Borer JS; Comerford MB; Sowton E
J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
[TBL] [Abstract][Full Text] [Related]
27. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
Araki H; Hayata N; Nakamura M
Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic effectiveness of the transdermal system with nitroglycerin in comparison with nifedipine].
Wester HA; Mouselimis N
Z Kardiol; 1984 Aug; 73(8):510-4. PubMed ID: 6437092
[TBL] [Abstract][Full Text] [Related]
29. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
[TBL] [Abstract][Full Text] [Related]
30. [Clinical experiences in patients with coronary heart disease and angina pectoris].
Sölter H
Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
[TBL] [Abstract][Full Text] [Related]
31. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
32. [Anti-ischemic action of the transdermally-applied beta-receptor blocker, mepindolol, in patients with stable angina pectoris. Comparison with transdermal nitrate].
Bonelli J; Gazo F; Falkner C; Liedtke RK
Arzneimittelforschung; 1990 Aug; 40(8):876-9. PubMed ID: 1978680
[TBL] [Abstract][Full Text] [Related]
33. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris.
Turner GG; Nelson RR; Nordstrom LA; Diefenthal HC; Gobel FL
Br Heart J; 1978 Dec; 40(12):1361-70. PubMed ID: 32899
[No Abstract] [Full Text] [Related]
34. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
Bonelli J; Gazo F; Liedtke RK
Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
[TBL] [Abstract][Full Text] [Related]
35. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
Libretti A; Gregorini L; Valentini R
Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
[No Abstract] [Full Text] [Related]
36. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effect of Inula racemosa (pushkarmoola) in angina pectoris: a preliminary report.
Tripathi SN; Upadhyaya BN; Gupta VK
Indian J Physiol Pharmacol; 1984; 28(1):73-5. PubMed ID: 6436179
[No Abstract] [Full Text] [Related]
38. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
Petrov IN; Rumiantsev AS; Smirnov MV
Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Sustac on ECG changes, effort tolerance and wellbeing of patients with angina pectoris].
Moczurad K; Wójcikiewicz O; Sedziwy L; Mareczek S; Sniezek M; Bielecki A
Pol Tyg Lek; 1977 Nov; 32(47):1847-50. PubMed ID: 414215
[No Abstract] [Full Text] [Related]
40. Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
Rydén L
Drugs; 1989; 38 Suppl 2():66. PubMed ID: 2575984
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
